Nano dimensions/adjuvants in COVID-19 vaccines
Discussion on Nano dimensions/adjuvants in COVID-19 vaccines
Edouard Alphandéry. J. Mater. Chem. B, 2022,10, 1520-1552.
Preclinical proof of concepts of the treatment developed by AlphaOnco have been developped pre-clinicaly and tested on different solid and organ-confined tumors.
Edouard Alphandéry ranked in the Stanford/Elsevier Top 2% Scientists List for the years 2020, 2021, 2022, 2023, 2024 and 2025.